<p>Early prediction of disability progression in multiple sclerosis (MS) remains challenging despite its critical importance for therapeutic decision-making. We present the first systematic evaluation of personalized federated learning (PFL) for 2-year MS disability progression prediction, leveraging multi-center real-world data from over 26,000 patients. While conventional federated learning (FL) enables privacy-aware collaborative modeling, it remains vulnerable to institutional data heterogeneity. PFL overcomes this challenge by adapting shared models to local data distributions without compromising privacy. We evaluated two personalization strategies: a novel AdaptiveDualBranchNet architecture with selective parameter sharing, and personalized fine-tuning of global models, benchmarked against centralized and client-specific approaches. Baseline FL underperformed relative to personalized methods, whereas personalization significantly improved performance, with personalized FedProx and FedAVG achieving ROC-AUC scores of 0.8398 ± 0.0019 and 0.8384 ± 0.0014, respectively. These findings establish personalization as critical for scalable, privacy-aware clinical prediction models and highlight its potential to inform earlier intervention strategies in MS and beyond.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

  • Ashkan Pirmani,
  • Edward De Brouwer,
  • Ádám Arany,
  • Martijn Oldenhof,
  • Antoine Passemiers,
  • Axel Faes,
  • Tomas Kalincik,
  • Serkan Ozakbas,
  • Riadh Gouider,
  • Barbara Willekens,
  • Dana Horakova,
  • Eva Kubala Havrdova,
  • Francesco Patti,
  • Alexandre Prat,
  • Alessandra Lugaresi,
  • Valentina Tomassini,
  • Pierre Grammond,
  • Elisabetta Cartechini,
  • Izanne Roos,
  • Cavit Boz,
  • Raed Alroughani,
  • Maria Pia Amato,
  • Katherine Buzzard,
  • Jeannette Lechner-Scott,
  • Joana Guimarães,
  • Claudio Solaro,
  • Oliver Gerlach,
  • Aysun Soysal,
  • Jens Kuhle,
  • Jose Luis Sanchez-Menoyo,
  • Daniele Spitaleri,
  • Tunde Csepany,
  • Bart Van Wijmeersch,
  • Radek Ampapa,
  • Julie Prevost,
  • Samia J. Khoury,
  • Vincent Van Pesch,
  • Nevin John,
  • Davide Maimone,
  • Bianca Weinstock-Guttman,
  • Guy Laureys,
  • Pamela McCombe,
  • Yolanda Blanco,
  • Ayse Altintas,
  • Abdullah Al-Asmi,
  • Justin Garber,
  • Anneke Van der Walt,
  • Helmut Butzkueven,
  • Koen de Gans,
  • Csilla Rozsa,
  • Bruce Taylor,
  • Talal Al-Harbi,
  • Attila Sas,
  • Cecilia Rajda,
  • Orla Gray,
  • Danny Decoo,
  • William M. Carroll,
  • Allan G. Kermode,
  • Marzena Fabis-Pedrini,
  • Deborah Mason,
  • Angel Perez-Sempere,
  • Mihaela Simu,
  • Neil Shuey,
  • Bhim Singhal,
  • Marija Cauchi,
  • Todd A. Hardy,
  • Sudarshini Ramanathan,
  • Patrice Lalive,
  • Carmen-Adella Sirbu,
  • Stella Hughes,
  • Tamara Castillo Trivino,
  • Liesbet M. Peeters,
  • Yves Moreau

摘要

Early prediction of disability progression in multiple sclerosis (MS) remains challenging despite its critical importance for therapeutic decision-making. We present the first systematic evaluation of personalized federated learning (PFL) for 2-year MS disability progression prediction, leveraging multi-center real-world data from over 26,000 patients. While conventional federated learning (FL) enables privacy-aware collaborative modeling, it remains vulnerable to institutional data heterogeneity. PFL overcomes this challenge by adapting shared models to local data distributions without compromising privacy. We evaluated two personalization strategies: a novel AdaptiveDualBranchNet architecture with selective parameter sharing, and personalized fine-tuning of global models, benchmarked against centralized and client-specific approaches. Baseline FL underperformed relative to personalized methods, whereas personalization significantly improved performance, with personalized FedProx and FedAVG achieving ROC-AUC scores of 0.8398 ± 0.0019 and 0.8384 ± 0.0014, respectively. These findings establish personalization as critical for scalable, privacy-aware clinical prediction models and highlight its potential to inform earlier intervention strategies in MS and beyond.